These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 37950156)
41. Identification and verification of an exosome-related gene risk model to predict prognosis and evaluate immune infiltration for colorectal cancer. Shao H; Yao L; Tao Y; Huang X Medicine (Baltimore); 2023 Oct; 102(40):e35365. PubMed ID: 37800824 [TBL] [Abstract][Full Text] [Related]
42. Identification of a six-gene prognostic signature for bladder cancer associated macrophage. Jiang Y; Qu X; Zhang M; Zhang L; Yang T; Ma M; Jing M; Zhang N; Song R; Zhang Y; Yang Z; Zhang Y; Pu Y; Fan J Front Immunol; 2022; 13():930352. PubMed ID: 36275756 [TBL] [Abstract][Full Text] [Related]
43. Cross-Talk Between m Song W; Ren J; Xiang R; Yuan W; Fu T Front Immunol; 2022; 13():740960. PubMed ID: 35350786 [TBL] [Abstract][Full Text] [Related]
44. A five-immune-related genes-based prognostic signature for colorectal cancer. Zhu L; Wang H; Wang Z Int Immunopharmacol; 2020 Nov; 88():106866. PubMed ID: 32781411 [TBL] [Abstract][Full Text] [Related]
45. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma. Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D Front Immunol; 2022; 13():944286. PubMed ID: 36591255 [TBL] [Abstract][Full Text] [Related]
46. Identification of macrophage-related molecular subgroups and risk signature in colorectal cancer based on a bioinformatics analysis. Liu Q; Liao L Autoimmunity; 2024 Dec; 57(1):2321908. PubMed ID: 38466182 [TBL] [Abstract][Full Text] [Related]
47. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis. Li J; Li L; Li Y; Long Y; Zhao Q; Ouyang Y; Bao W; Gong K Int J Colorectal Dis; 2020 Jul; 35(7):1203-1210. PubMed ID: 32303831 [TBL] [Abstract][Full Text] [Related]
48. Identification and Validation of the Glycolysis and Immune-related Gene Signature for Prognosis in Colorectal Cancer. Jiang M; Liu Y; Xu J; Xu Z; Ye T; Li S; Jiang C Anticancer Res; 2024 Jan; 44(1):117-131. PubMed ID: 38159970 [TBL] [Abstract][Full Text] [Related]
49. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer. Yue Y; Zhang Q; Sun Z Front Immunol; 2021; 12():758040. PubMed ID: 35140706 [TBL] [Abstract][Full Text] [Related]
50. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer. Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136 [TBL] [Abstract][Full Text] [Related]
51. A signature based on 11 autophagy genes for prognosis prediction of colorectal cancer. Chen S; Wang Y; Wang B; Zhang L; Su Y; Xu M; Zhang M PLoS One; 2021; 16(10):e0258741. PubMed ID: 34699544 [TBL] [Abstract][Full Text] [Related]
52. Validating a Macrophage Marker Gene Signature (MMGS) in Lung Adenocarcinoma Prognosis and Response to Immunotherapy. Song P; Wusiman D; Li W; Guo L; Ying J; Gao S; He J J Immunother; 2023 Jul-Aug 01; 46(6):205-215. PubMed ID: 37220007 [TBL] [Abstract][Full Text] [Related]
53. Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma. He Z; Gu Y; Yang H; Fu Q; Zhao M; Xie Y; Liu Y; Du W J Cancer Res Clin Oncol; 2023 Oct; 149(13):11661-11678. PubMed ID: 37402968 [TBL] [Abstract][Full Text] [Related]
54. NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer. Hong SM; Lee AY; Kim BJ; Lee JE; Seon SY; Ha YJ; Ng JT; Yoon G; Lim SB; Morgan MJ; Cha JH; Lee D; Kim YS Adv Sci (Weinh); 2024 Apr; 11(14):e2303177. PubMed ID: 38308188 [TBL] [Abstract][Full Text] [Related]
55. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer. Wang Z; Liu H; Gong Y; Cheng Y Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948 [TBL] [Abstract][Full Text] [Related]
56. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer. Chen T; Yang C; Dou R; Xiong B Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341 [TBL] [Abstract][Full Text] [Related]
57. A novel anoikis-related gene prognostic signature and its correlation with the immune microenvironment in colorectal cancer. Xiao Y; Zhou H; Chen Y; Liu L; Wu Q; Li H; Lin P; Li J; Wu J; Tang L Front Genet; 2023; 14():1186862. PubMed ID: 37323657 [No Abstract] [Full Text] [Related]
58. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma. Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951 [TBL] [Abstract][Full Text] [Related]
59. Identification and validation of a metabolism-related gene signature for the prognosis of colorectal cancer: a multicenter cohort study. Han P; Yang X; Li L; Bao J; Zhang W; Zai S; Zhu Z; Wu M Jpn J Clin Oncol; 2022 Nov; 52(11):1327-1336. PubMed ID: 35848857 [TBL] [Abstract][Full Text] [Related]
60. Exploration and validation of a combined immune and metabolism gene signature for prognosis prediction of colorectal cancer. Xiao Y; Zhang G; Wang L; Liang M Front Endocrinol (Lausanne); 2022; 13():1069528. PubMed ID: 36518242 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]